Ver mas grande
ELISA Kit for Clusterin (CLU)
CC-SEB180Hu
Producto nuevo
48T, 96T, 96T×5, 96T×10, 96T×100
Comprando este producto generará 5 Biopuntos. Su cesta contiene un total 5 Biopuntos puede ser convertido en un Biobonos Descuento 20.00EUR.
Hoja técnica
| Size | 96T |
| Storage Conditions | -20°C |
| Shipping Conditions | Entre 4°C y 8°C |
| Applications | Enzyme-linked immunosorbent assay for Antigen Detection. |
| Detection Range | 12.5-800ng/mL |
| Sensitivity | The minimum detectable dose of this kit is typically less than 5.1ng/mL |
| Research Area | Apoptosis |
| Organism species | Homo sapiens (Human) |
| Alternative Names | CLU |
| Item Name | Clusterin |
| Assay Length | 3h |
| Method | Double-antibody Sandwich |
| Sample Type | Serum, plasma, urine, saliva, tissue homogenates, cerebrospinal fluid, cell culture supernates and other biological fluids |
| Formato | 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100 |
| Test Principle | The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Clusterin (CLU). Standards or samples are then added to the appropriate microtiter plate well |
| Assay procedure summary | 1. Prepare all reagents, samples and standards |
| UniProt ID | P10909 |
Más información
CITATIONS
Time-Dependent Decrease of Clusterin as a Potential Cerebrospinal Fluid Biomarker for Drug-Resistant Epilepsy.;Serum Amyloid A and Clusterin as Potential Predictive Biomarkers for Severe Hand, Foot and Mouth Disease by 2D-DIGE Proteomics Analysis;Proteomic analysis of human plasma and peripheral blood mononuclear cells in Systemic Lupus Erythematosus patients.;Proteomics Analysis of Blood Serums from Alzheimer's Disease Patients Using iTRAQ LabelingTechnology.;Clusterin, a New Cerebrospinal Fluid Biomarker in Severe Subarachnoid Hemorrhage: A Pilot Study;Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis;High serum clusterin levels are correlated with premature coronary artery disease in a Chinese population;Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer;